Keyphrases
Drug Use
100%
Drug Safety
100%
Allergic Rhinitis
100%
Fetal Safety
100%
Loratadine
75%
During Pregnancy
50%
Intranasal Corticosteroids
50%
First-generation Antihistamines
50%
Decongestants
50%
Desloratadine
50%
Pharmacological Intervention
25%
Meta-analysis
25%
Systemic Effects
25%
Patient Information
25%
Low Risk
25%
Treatment Options
25%
Human Studies
25%
First Trimester
25%
Comparative Efficacy
25%
Congenital Malformations
25%
Cromolyn Sodium
25%
Safety Profile
25%
Intranasal
25%
Effective Therapy
25%
Risk-benefit
25%
Patient Cohort
25%
Antihistamines
25%
Drug Label
25%
Sodium Cromoglycate
25%
Safe Treatment
25%
Fetal Outcome
25%
H1-antihistamines
25%
Safer Alternatives
25%
Major Congenital Malformations
25%
Budesonide
25%
Teratogenic Risk
25%
Drugs in Pregnancy
25%
Systemic Absorption
25%
Risk Consideration
25%
Mast Cell Stabilizer
25%
Oral Antihistamines
25%
Label Information
25%
Most Common Allergic Diseases
25%
Beclometasone
25%
Medicine and Dentistry
Histamine Antagonist
100%
Allergic Rhinitis
100%
Loratadine
60%
Congenital Malformation
40%
Cromoglycate Disodium
40%
Decongestant
40%
Desloratadine
40%
Disease
20%
Clinician
20%
Meta-Analysis
20%
Human Study
20%
First Trimester Pregnancy
20%
Metabolite
20%
Immunotherapy
20%
Beclometasone
20%
Budesonide
20%
Histamine Release Inhibitor
20%
Pharmacology, Toxicology and Pharmaceutical Science
Antihistaminic Agent
100%
Allergic Rhinitis
100%
Loratadine
60%
Congenital Malformation
40%
Cromoglicic Acid
40%
Decongestive Agent
40%
Desloratadine
40%
Disease
20%
Human Study
20%
Immunotherapy
20%
Beclometasone
20%
Budesonide
20%
Histamine Release Inhibitor
20%
Immunology and Microbiology
Allergic Rhinitis
100%
Loratadine
75%
Cromoglicic Acid
50%
Desloratadine
50%
Metabolite
25%
Absorption
25%
Immunotherapy
25%
First Trimester Pregnancy
25%
Budesonide
25%
Mast Cell Stabilizer
25%